More participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...
Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...
Leading European venture capital firm Sofinnova Partners today announced it has raised 1.2 billion euros ($1.25 billion) ...
Roivant Sciences portfolio company Genevant Sciences and Canada’s Arbutus Biopharma yesterday filed five international ...
SBI Magnum Midcap Fund - Direct (G) 226.08 4,09,188 1.07 SBI Magnum Midcap Fund - Direct (IDCW) 226.08 4,09,188 1.07 Aditya Birla SL Frontline Equity Fund (G) 138.54 2,50,741 0.49 Aditya Birla SL ...